Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer

Caram, MEV; Ross, R; Lin, P; Mukherjee, B

Caram, MEV (reprint author), Univ Michigan, Dept Internal Med, Div Hematol Oncol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.

JAMA NETWORK OPEN, 2019; 2 (4):

Abstract

IMPORTANCE Sipuleucel-T is an immunotherapy that has been approved for use in patients with asymptomatic or minimally symptomatic metastatic castratio......

Full Text Link